These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 1882952)

  • 1. Interferon alpha 2a for treatment of age-related macular degeneration.
    Fung WE
    Am J Ophthalmol; 1991 Sep; 112(3):349-50. PubMed ID: 1882952
    [No Abstract]   [Full Text] [Related]  

  • 2. Interferon treatment of SRNV.
    Donahue SP; Wall M; Weingeist TA
    Ophthalmology; 1994 Apr; 101(4):624-5. PubMed ID: 8152753
    [No Abstract]   [Full Text] [Related]  

  • 3. Antiangiogenic therapy with interferon alfa for neovascular age-related macular degeneration.
    Reddy U; Kryzstolik M
    Cochrane Database Syst Rev; 2006 Jan; (1):CD005138. PubMed ID: 16437522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical experience with interferon alfa-2a for exudative age-related macular degeneration.
    Kirkpatrick JN; Dick AD; Forrester JV
    Br J Ophthalmol; 1993 Dec; 77(12):766-70. PubMed ID: 7509185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complete regression of retinal neovascularization after therapy with interferon alfa in Behçet's disease.
    Stuebiger N; Koetter I; Zierhut M
    Br J Ophthalmol; 2000 Dec; 84(12):1437-8. PubMed ID: 11186866
    [No Abstract]   [Full Text] [Related]  

  • 6. Systemic interferon-alpha 2a and subretinal neovascular membranes.
    Constable I
    Aust N Z J Ophthalmol; 1992 Aug; 20(3):155. PubMed ID: 1280446
    [No Abstract]   [Full Text] [Related]  

  • 7. Extracts from "clinical evidence": age related macular degeneration.
    Arnold JJ; Sarks SH
    BMJ; 2000 Sep; 321(7263):741-4. PubMed ID: 10999909
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of choroidal neovascularisation in age-related macular degeneration with interferon alfa-2a and alfa-2b.
    Gillies MC; Sarks JP; Beaumont PE; Hunyor AB; McKay D; Kearns M; McClusky PJ; Sarks SH
    Br J Ophthalmol; 1993 Dec; 77(12):759-65. PubMed ID: 7509184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of age-associated macular degeneration with interferon-alfa-2a].
    Thölen A; Kain H; Messmer E
    Ophthalmologe; 1993 Jun; 90(3):279-82. PubMed ID: 8334332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. We are very spoiled.
    Fine SL; Maguire MG
    Arch Ophthalmol; 1997 Jul; 115(7):915-6. PubMed ID: 9230835
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of choroidal neovascularization in age-related macular degeneration with interferon alpha-2a: a short term, nonrandomized pilot study.
    Thoelen A; Menozzi M; Huber C; Messmer E
    Ger J Ophthalmol; 1995 May; 4(3):137-43. PubMed ID: 7545047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age related macular degeneration.
    Arnold J
    Clin Evid; 2006 Jun; (15):877-88. PubMed ID: 16973036
    [No Abstract]   [Full Text] [Related]  

  • 13. Age related macular degeneration.
    Arnold J
    Clin Evid; 2005 Jun; (13):762-75. PubMed ID: 16135278
    [No Abstract]   [Full Text] [Related]  

  • 14. Age related macular degeneration.
    Arnold J; Sarks S
    Clin Evid; 2004 Jun; (11):819-34. PubMed ID: 15652038
    [No Abstract]   [Full Text] [Related]  

  • 15. Age related macular degeneration.
    Arnold J; Sarks S
    Clin Evid; 2003 Dec; (10):727-43. PubMed ID: 15555119
    [No Abstract]   [Full Text] [Related]  

  • 16. Interferon alpha-2a for proliferative diabetic retinopathy after complete laser panretinal photocoagulation treatment.
    Leibovitch I; Loewenstein A; Alster Y; Rosenblatt I; Lazar M; Yassur Y; Rubinstein A
    Ophthalmic Surg Lasers Imaging; 2004; 35(1):16-22. PubMed ID: 14750758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New treatments for neovascular acute macular degeneration.
    Chakravarthy U; Lim JI
    BMJ; 2007 Feb; 334(7588):269-70. PubMed ID: 17289688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [New perspectives in the approach to age-related macular degeneration].
    Gallego-Pinazo R; Zapata MA
    Arch Soc Esp Oftalmol; 2015 Mar; 90 Suppl 1():11-4. PubMed ID: 25925046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Higher incidence of retinal pigment epithelium tears after ranibizumab in neovascular age-related macular degeneration with increasing pigment epithelium detachment height.
    Guber J; Praveen A; Saeed MU
    Br J Ophthalmol; 2013 Nov; 97(11):1486-7. PubMed ID: 24037605
    [No Abstract]   [Full Text] [Related]  

  • 20. Triamcinolone for occult exudative age-related macular degeneration.
    Gillies MC; Simpson JM; Zhu M
    Am J Ophthalmol; 2006 Jan; 141(1):228; author reply 228-9. PubMed ID: 16387021
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.